Capecitabine
NDC 68001-643, Capecitabine, tablet, film coated, from BluePoint Laboratories.
- Product NDC
- 68001-643
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210203
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-643 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAPECITABINE150 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-643-06 | 68001064306 | 60 TABLET, FILM COATED in 1 BOTTLE (68001-643-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/88c5af84-900a-4372-b056-bfea70c129cfMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-643NADAC price for package 68001064306
GET /v1/drugs/nadac/68001064306
Use it
Look up 68001-643 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-643 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-643. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.